ConductScience.org, home

Paper32272076

Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?

Klasse PJ and 3 others. Cell Host Microbe, 2020. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens? Papers, record 32272076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32272076

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?
PubMed
Journal
Cell Host Microbe
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2024-12-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klasse PJP J
2Ozorowski GGabriel
3Sanders RWRogier W
4Moore JPJohn P

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV AntibodiesMajor topic
HIV-1Major topic
env Gene Products, Human Immunodeficiency VirusMajor topic
AIDS Vaccines
Adaptive Immunity
Antibodies, Neutralizing
B-Lymphocytes
CD4 Antigens
Epitopes, B-Lymphocyte
Immunity, Innate
Mannose
Membrane Glycoproteins
Molecular Mimicry
Protein Binding
Protein Multimerization
T-Lymphocytes

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P01 AI110657NIAID NIH HHSUnited StatesP01AI110657PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References155

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130971821Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET.Nature2019https://conductscience.org/library/papers/30971821PubMed
229162799Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding.Nat Commun2017https://conductscience.org/library/papers/29162799PubMed
331097697Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage.Nat Commun2019https://conductscience.org/library/papers/31097697PubMed
429220496Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies.J Infect Dis2018https://conductscience.org/library/papers/29220496PubMed
530190230When designing vaccines, consider the starting material: the human B cell repertoire.Curr Opin Immunol2018https://conductscience.org/library/papers/30190230PubMed
612193713Role of disulfide bonds in regulating antigen processing and epitope selection.J Immunol2002https://conductscience.org/library/papers/12193713PubMed
731271322Novel prime-boost vaccine strategies against HIV-1.Expert Rev Vaccines2019https://conductscience.org/library/papers/31271322PubMed
812804865Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin.Vaccine2003https://conductscience.org/library/papers/12804865PubMed
929794117Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity.J Exp Med2018https://conductscience.org/library/papers/29794117PubMed
1027843002Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice.Vaccine2016https://conductscience.org/library/papers/27843002PubMed
1125349379Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25349379PubMed
1223700434Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells.PLoS One2013https://conductscience.org/library/papers/23700434PubMed
137903129Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein.Virology1994https://conductscience.org/library/papers/7903129PubMed
1425681373Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/25681373PubMed
1528847869Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo.J Exp Med2017https://conductscience.org/library/papers/28847869PubMed
1626491081Immune correlates of vaccine protection against HIV-1 acquisition.Sci Transl Med2015https://conductscience.org/library/papers/26491081PubMed
1721762802HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.J Mol Biol2011https://conductscience.org/library/papers/21762802PubMed
1810716904Helper T-cell epitope immunodominance associated with structurally stable segments of hen egg lysozyme and HIV gp120.J Theor Biol2000https://conductscience.org/library/papers/10716904PubMed
1927309817Design of a hyperstable 60-subunit protein dodecahedron. [corrected].Nature2016https://conductscience.org/library/papers/27309817PubMed
2028539451Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers.J Virol2017https://conductscience.org/library/papers/28539451PubMed

See all 155 referencesDownload CSV of references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
42931443Advances in HIV-1 Envelope-Based Vaccine Development.Vaccines (Basel)2026https://conductscience.org/library/papers/42931443PubMed
41959402Decoding epitope immunodominance in HIV Env using cryoEM and machine learning.bioRxiv2026https://conductscience.org/library/papers/41959402PubMed
41373539Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection.Int J Mol Sci2025https://conductscience.org/library/papers/41373539PubMed
41334187Beyond monotherapy: Combination therapies for HIV-1 cure through joint application of neutralizing antibodies, genome editing, and reservoir management.Infect Med (Beijing)2025https://conductscience.org/library/papers/41334187PubMed
41112192Bridging Viral Glycobiology and Lectin Biotechnology for Antiviral and Diagnostic Strategies.ACS Bio Med Chem Au2025https://conductscience.org/library/papers/41112192PubMed
40835839Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques.NPJ Vaccines2025https://conductscience.org/library/papers/40835839PubMed
40708523Unveiling an Immunological Mystery: Deciphering the Durability Divide in Vaccine-Elicited Antibody Responses.Curr HIV Res2026https://conductscience.org/library/papers/40708523PubMed
40702326The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.Nat Rev Microbiol2025https://conductscience.org/library/papers/40702326PubMed
40461490Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response.Nat Commun2025https://conductscience.org/library/papers/40461490PubMed
39651156Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques.bioRxiv2025https://conductscience.org/library/papers/39651156PubMed
39372389Clinical glycoproteomics: methods and diseases.MedComm (2020)2024https://conductscience.org/library/papers/39372389PubMed
39361585Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes.PLoS Pathog2024https://conductscience.org/library/papers/39361585PubMed
39303017Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response.Sci Immunol2024https://conductscience.org/library/papers/39303017PubMed
38628675The Question of HIV Vaccine: Why Is a Solution Not Yet Available?J Immunol Res2024https://conductscience.org/library/papers/38628675PubMed
37903160Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.PLoS Pathog2023https://conductscience.org/library/papers/37903160PubMed
37244989Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.Retrovirology2023https://conductscience.org/library/papers/37244989PubMed
37044090Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.Cell Rep Med2023https://conductscience.org/library/papers/37044090PubMed
37031217Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimmers as HIV-1 vaccine candidates.Nat Commun2023https://conductscience.org/library/papers/37031217PubMed
37014912Essential role of an ERV-derived Env38 protein in adaptive humoral immunity against an exogenous SVCV infection in a zebrafish model.PLoS Pathog2023https://conductscience.org/library/papers/37014912PubMed
36255672Synthesis, Processing, and Function of N-Glycans in N-Glycoproteins.Adv Neurobiol2023https://conductscience.org/library/papers/36255672PubMed

See all 44 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32272076

GET https://conductscience.org/api/papers/v1/32272076/references?page=2